<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04236375</url>
  </required_header>
  <id_info>
    <org_study_id>Eye movement-cognitive decline</org_study_id>
    <nct_id>NCT04236375</nct_id>
  </id_info>
  <brief_title>Eye Movement and Cognitive Dysfunction</brief_title>
  <acronym>EMCD</acronym>
  <official_title>The Development of an Artificial Intelligence Platform for Screening and Referral of Cognitive Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is association between eye movement disorder and cognitive dysfunction. Therefore,
      utilizing eye movement and screening for cognitive dysfunction is feasible. In the present
      study, we will develop an artificial intelligence platform to screening for cognitive
      dysfunction by inspecting the function of eye movement. Futher more, based on the screening
      results, the platform will offer referral suggestions.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve</measure>
    <time_frame>up to 1 month</time_frame>
    <description>AUC values for predicting whether subject has cognitive impairment or not</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy, true positive rate, and true negetive rate</measure>
    <time_frame>up to 1 month</time_frame>
    <description>The performance of this artificial platform</description>
  </secondary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Eye Movement Disorder</condition>
  <condition>Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>Subjects over 45 years old without cognitive dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild cognitive decline</arm_group_label>
    <description>Subjects who are diagnosed as mild cognitive decline(MCI) according to neurologists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alzheimer's disease</arm_group_label>
    <description>Subjects who are diagnosed as Alzheimer's disease(AD) according to neurologists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vascular dementia</arm_group_label>
    <description>Subjects who are diagnosed as vascular dementia(VD) according to neurologists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lewy body dementia</arm_group_label>
    <description>Subjects who are diagnosed as Lewy body demenita (DLB) according to neurologists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frontotemporal dementia</arm_group_label>
    <description>Subjects who are diagnosed as Frontotemporal demenita (FD) according to neurologists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other dementia</arm_group_label>
    <description>Subjects who are diagnosed as dementia but are not as AD, VD, DLB OR FD.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who are over 45 years old with or without cognitive dysfunction.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ①Subjects who are diagnosed as mild cognitive decline, Alzheimer's disease, Vascular
             dementia, Lewy body dementia, Frontotemporal dementia, other dementia and normal by
             neurologist.

          -  ②Subjects who can cooperate with the inspection.

          -  ③Subjects who agree to participate in the study and sign the consent form

        Exclusion Criteria:

          -  ①Subjects who cannot do the inspection.

          -  ②Subjects who suffer from diseases that compromise the inspection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haotian Lin, M.D.,Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xun Wang, M.D.,Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shuyi Zhang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haotian Lin, M.D.,Ph.D</last_name>
    <phone>86-13802793086</phone>
    <email>gddlht@aliyun.com</email>
  </overall_contact>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 18, 2020</study_first_submitted>
  <study_first_submitted_qc>January 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2020</study_first_posted>
  <last_update_submitted>January 18, 2020</last_update_submitted>
  <last_update_submitted_qc>January 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Movement Disorders</mesh_term>
    <mesh_term>Ocular Motility Disorders</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

